Brand profile · Mental Health Care

Emyria (ASX:EMD)

Emyria is a Mental Health Care brand in Leederville, Western Australia. Ownership is publicly held; it publishes at emyria.com. It holds one address on record, all in Australia. The record counts 16 people. Its latest round on record is Post IPO equity, US$2.5M. It is listed alongside seven similar brands, mostly in IT Services & Consulting.

Profile live Public Company 1 office country US$ 2.5M Post IPO equity

Key facts

Counted staff
16
self-reported 11–50 band
Founded
Not recorded
Legal entities
None matched
Office countries
1
1 address
Funding rounds
2
Post IPO equity · Jun 2023 · US$ 2.5M
Company type
Public Company
self-reported
Use this profile Compare Your shortlist

Description

Emyria Limited is a clinical services and drug development company focused on improving patient outcomes in neuroscience and mental health via a unique business model:

Emyria Care: Deliver evidence-based and emerging therapies for mental health and other unmet needs across multiple sites (Empax Centres).

Emyria Data: Robust and ethically-sourced Real-World Data gathered with patients. Emyria Data is used to improve Emyria’s distinct therapy and drug development programs.

Emyria Drug Discovery: One of the world's largest libraries of unique MDMA-like compounds developed in partnership with the University of Western Australia for a range of mental health and select neuroscience indications.

Locations

Country footprint

Offices in 1 countryCountry footprint: 1 country, primary AU. Codes: AU.1 countryprimary AUAU
Show as table · Offices in 1 country
Offices in 1 country
Countries1
Primary countryAU

All codes: AU

Addresses

  • AU661 Newcastle St; Leederville, Western Australia 6007Primary

Grid intelligence Members

Funding

Last round · 1 June 2023US$ 2.5MPost IPO equity
Rounds2
Round typePost IPO equity · secondary transaction
Amount (USD)2,500,000
Stage rank6
Investors named0
Since last round2 yr 7 mo

Funding

2 funding roundsFunding timeline. Latest round 1 Jun 2023: Post IPO equity, US$ 2.5M.20232026Post IPO equityUS$ 2.5M2 rounds
Show as table · 2 funding rounds
2 funding rounds
Rounds2
Axis2023 to 2026
Post IPO equity · 1 Jun 2023US$ 2.5M

Dated rounds only. The axis ends at the date this profile was last observed, not at today.

Spending power

TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.

Spending power

Signals & hiring

Hiring, headcount and registry-change signals, streamed to members.

Latest signal
Hiring activity
Headcount trend

Financials

Registry-filed capital and financial indicators, standardised by TheGrid.

Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss

People & contacts

4 employee profiles on record · names withheld.

Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.

Counts only. No names are stored here, and none are served.

Notify me about contacts Tell us who you need to reach and we will tell you when a consented source is live.

FAQ

How many people work at Emyria (ASX:EMD)?

The record holds 16 counted staff profiles at January 2026, inside the self-reported 11–50 band.

Where does Emyria (ASX:EMD) have offices?

One address on record, Australia only. Primary: 661 Newcastle St, Leederville, Western Australia 6007.

Has Emyria (ASX:EMD) raised funding?

Two rounds. Latest 1 June 2023: post IPO equity, US$2,500,000.

Which companies are listed alongside Emyria (ASX:EMD)?

Seven peer profiles on record: StrongRoom AI and SafeStyle.

What is Emyria (ASX:EMD)'s website?